YAU YI CHING 4
4 · BridgeBio Pharma, Inc. · Filed Dec 16, 2019
Insider Transaction Report
Form 4
YAU YI CHING
Chief Accounting Officer
Transactions
- Award
Restricted Stock Units
2019-12-12+55,652→ 55,652 total→ Common Stock (55,652 underlying)
Footnotes (2)
- [F1]Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date.
- [F2]The units shall vest as to 25% of the units on February 16, 2021, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.